baber/WOPTO huggingface dataset:
Patent AT-E295702-T1 (AT)
Inventor: LEE ROBERTA
IPC: A61B10/02
Filed: 1999-08-20
Granted: 2005-06-15
Abstract: An excisional biopsy device (100) includes a tubular member (110) having a window (120) near a distal tip (115) thereof; a cutting tool (125), a distal end of the cutting tool being attached near the distal tip of the tubular member, at least a distal portion of the cutting tool (125) being configured to selectively bow out of the window and to retract within the window; and a tissue collection device (260) externally attached at least to the tubular member, the tissue collection device collecting tissue excised by the cutting tool as the biopsy device is rotated and the cutting tool is bowed. An excisional biopsy method for soft tissue includes the steps of inserting a generally tubular member into the tissue, the tubular member including a cutting tool adapted to selectively bow away from the tubular member and an external tissue collection device near a distal tip of the tubular member; rotating the tubular member; selectively varying a degree of bowing of the cutting tool; collecting tissue severed by the cutting tool in the tissue collection device; and retracting the tubular member from the soft tissue. The tubular member may include an imaging transducer (270) and the method may include the step of displaying information received from the transducer on a display device and the step of varying the degree of bowing of the cutting tool based upon the displayed information from the imaging transducer. Alternatively, the imaging transducer (270) may be disposed within a removable transducer core adapted to fit within the tubular member.
Patent AT-E318196-T1 (AT)
Inventor: AZKONA OLLACARIZQUETA MANUEL
IPC: B25B7/10
Filed: 1999-12-15
Granted: 2006-03-15
Abstract: The pliers comprises of two jaws (11,12) that are formed at the end of two elongate sections that form handles at the other The two sections are joined at a pivot that includes a thumb operated ratchet (52). This engages teeth (51) formed on the inner surface of a straight slot. Opening the ratchet enables the closed clearance of the jaws to be varied according to the intended application.
Patent AT-E224131-T1 (AT)
Inventor: LOWE JOHN MICHAEL
IPC: H05K13/02
Filed: 1999-01-28
Granted: 2002-09-15
Abstract: A component placement apparatus including a head mount having at least one pick and place head; component carrier; and component receiver, the at least one pick and place head being arranged to pick up a component from the component carrier and place it on the component receiver, wherein the head mount is movable to move the at least one pick and place head in a single plane; the component carrier is movable in a plane transverse to the at least one pick and place head at a pick up position; and the component receiver is movable in a plane transverse to the at least one pick and place head at a placement position.
Patent AT-E228978-T1 (AT)
Inventor: CHAWLA CHANDER PRAHASH
IPC: G02B6/44
Filed: 1999-09-01
Granted: 2002-12-15
Abstract: A radiation-curable, optical fiber coating composition has enhanced color stabilization and is formulated from a composition containing at least one radiation-curable oligomer or monomer. A concentration of urethane and ether linkages in the radiation-curable composition is such that a cured optical fiber coating formed from said radiation-curable composition exhibits a DELTAE of about 40 or less after being exposed for 96 hours to 150° C. and then for 144 hours to 180° C. Also provided is a radiation-curable optical fiber coating composition which is substantially urethane-free.
Patent AT-E217889-T1 (AT)
Inventor: ADAMS CAMELLIA W
IPC: G01N33/50
Filed: 1999-08-26
Granted: 2002-06-15
Abstract: The invention provides for the isolation, identification, synthesis, expression and purification of antibodies reactive with factor IX (FIX)/factor IXa (IXa). In particular aspects, the invention provides human antibodies reactive with the human FIX Gla domain. The invention further provides compositions especially pharmaceutical compositions, articles of manufacture, and methods of inhibiting the activation of FIX and inhibiting FIX/IXa dependent coagulation.
Patent AT-E246921-T1 (AT)
Inventor: WILSON ROBERT JOHN MACLEOD
IPC: A61K31/00
Filed: 1999-09-22
Granted: 2003-08-15
Abstract: An inhibitor of ycf 24 gene product expression and/or activity is used in a method of treatment of the human or animal body by therapy. In particular the inhibitor is used in a method of treatment of infection by an organism. The organism may be a malaria parasite, such as Plasmodium falciparum. The invention also provides a method of inhibiting the growth of an organism comprising contacting the organism ex vivo with an inhibitor of ycf 24 gene product expression and/or activity. The invention further provides a method of identifying a compound that inhibits the growth of an organism comprising (i) contacting a test compound with the ycf 24 gene product, and (ii) determining whether the test compound inhibits the activity of or binds to the product, any such binding or inhibition being indicative that the compound inhibits the growth of the organism.
Patent DE-08740855-T1 (DE)
Title: Einrichtung im fahrzeug und werbeinformations-verteilungssystem
Inventor: GOTO SOUJU
IPC: G07B15/06
Filed: 2008-04-25
Abstract: Vorrichtung im Fahrzeug, umfassend:  eine Kommunikationseinrichtung zum Kommunizieren mit einem Zentralgerät, das Werbeinformationen über eine Straßenrandfunkvorrichtung verteilt;  eine Anzeigeeinrichtung; und  eine Steuerungseinrichtung, welche arbeitet, um Sendeinformationen zu erzeugen, einschließlich zumindest einer oder aller der Informationen, die angeben, ob die Werbeinformationen aus dem Zentralgerät empfangen werden, Informationen, die angeben, ob die empfangenen Werbeinformationen von der Anzeigeinrichtung angezeigt werden, und Informationen, die angeben, ob ein Fahrzeug einen Punkt erreicht hat, der von den angezeigten Werbeinformationen genannt wird, und welche die Kommunikationseinrichtung veranlasst, die erzeugten Sendeinformationen ans Zentralgerät zu senden.
Patent DE-09001901-T1 (DE)
Inventor: MCCAFFERTY JOHN
IPC: G01N33/68
Filed: 1991-07-10
Abstract: A member of a specific binding pair (sbp) is identified by expressing DNA encoding a genetically diverse population of such sbp members in recombinant host cells in which the sbp members are displayed in functional form at the surface of a secreted recombinant genetic display package (rgdp) containing DNA encoding the sbp member or a polypeptide component thereof, by virtue of the sbp member or a polypeptide component thereof being expressed as a fusion with a capsid component of the rgdp. The displayed sbps may be selected by affinity with a complementary sbp member, and the DNA recovered from selected rgdps for expression of the selected sbp members. Antibody sbp members may be thus obtained, with the different chains thereof expressed, one fused to the capsid component and the other in free form for association with the fusion partner polypeptide. A phagemid may be used as an expression vector, with said capsid fusion helping to package the phagemid DNA. Using this method libraries of DNA encoding respective chains of such multimeric sbp members may be combined, thereby obtaining a much greater genetic diversity in the sbp members than could easily be obtained by conventional methods.
Patent ES-2037646-T1 (ES)
IPC: A61C8/00
Filed: 1992-03-23
Abstract: The osteointegrated assembly consists of a pin (10) on which is forcibly engaged a collar (20,20a). Said collar and pin are provided with opposite crowns (26,27 or 26', 27') apt to provide a perfect seal tight contact, to avoid fluid infiltration and the proliferation of bacterial colonies. Collars (20), of simple shape and low cost, can be stocked in a limited set of elements,varying practically only in height (H) which can be adjusted, case by case, to the thickness of the patient's connective tissue layer (S) provide for a wide range of combinations with the different lengths of pins (10), an easy securing of the prosthesis and a longer duration of the latter, without any negative secondary effects. <IMAGE>
Patent CY-1107565-T1 (CY)
Title: Ιμιδαζο-πυριμιδινες και τριαζολο-πιριμιδινες: συνδεσμοι υποδοχεα βανζοδιαζεπινης
Inventor: XIE LINGHONG
IPC: C07D487/04
Filed: 2007-02-26
Abstract: Παρέχονται ενώσεις του Τύπου (I), όπως και μέθοδοι για την παρασκευή τους. Οι μεταβλητές Z1, Ζ2, Ζ3, R4, R5, R6, R7, R8 και Ar στον παραπάνω τύπο ορίζονται στην παρούσα. Τέτοιες ενώσεις μπορούν να χρησιμοποιηθούν για να διαμορφώσουν την δέσμευση συνδέσμου σε υποδοχείς GABAA σε βιολογικό περιβάλλον ή σε χημικό περιβάλλον, και είναι ιδιαίτερα χρήσιμες στην θεραπεία μιας ποικιλίας διαταραχών του κεντρικού νευρικού συστήματος (ΚΝΣ) στους ανθρώπους, τα κατοικίδια ζώα συντροφιάς και στα ζώα κτηνοτροφίας. Οι ενώσεις παρεχόμενες στην παρούσα μπορούν να χορηγηθούν μόνες ή σε συνδυασμό με έναν ή περισσότερους άλλους παράγοντες του ΚΝΣ για δυναμικοποίηση των αποτελεσμάτων του άλλου παράγοντα(ων) του ΚΝΣ. Φαρμακευτικές συνθέσεις και μέθοδοι παρέχονται για την θεραπευτική αντιμετώπιση τέτοιων διαταραχών, όπως είναι οι μέθοδοι για την χρήση τέτοιων συνδέσμων για την ανίχνευση υποδοχέων GABAA (π.χ., μελέτες εντοπισμού υποδοχέων).
Patent CY-1111599-T1 (CY)
Title: Αναστολεις κινασης θειενοπυριδινης και φουροπυριδινης
Inventor: BETSCHMANN PATRICK
IPC: C07D498/04
Filed: 2009-03-12
Abstract: Ενώσεις που έχουν τον χημικό τύπο: (I), είναι χρήσιμες για την αναστολή κινασών τυροσίνης πρωτεΐνης. Στην παρούσα εφεύρεση αποκαλύπτονται και δημοσιοποιούνται ως αναφορά επίσης μέθοδοι για την παρασκευή των ενώσεων, των συνθέσεων που περιέχουν τις ενώσεις, και των μεθόδων αγωγής χρησιμοποιώντας τις ενώσεις.
Patent CY-1110778-T1 (CY)
Inventor: FERNANDEZ MATILDE IBANEZ
IPC: A61K31/546
Filed: 2010-09-13
Abstract: Composition (A) comprises cefuroxime axetil (I) in the form of particles, entirely enclosed in a coating of at least one lipid (insoluble in water but dispersing or decomposing in contact with gastrointestinal fluid), a bulk sweetener and a binder. (A) Also contains a sweetening system (II) and a texture modifier (III), in amounts so that the bitter taste of (I) is masked.  An Independent claim is included for an orally administered medicament (preferably in aqueous suspension or granule form), comprising (A) together with carriers or excipients.
Patent CY-1113858-T1 (CY)
Title: Παραγωγα πυριδιν-3-υλιου ως ανοσορυθμιστικοι παραγοντες
Inventor: BOLLI MARTIN
IPC: A61K31/4439
Filed: 2013-03-26
Abstract: Η εφεύρεση αφορά σε παράγωγα πυριδιν-3-υλίου του τύπου (I) όπου τα R1, R2, R3, R4, R5, R6 και Α έχουν όπως περιγράφεται στην περιγραφή, στην παρασκευή τους και στη χρήση τους ως φαρμακευτικά δραστικές ενώσεις. Οι εν λόγω ενώσεις δρουν ιδίως ως ανοσορυθμιστικοί παράγοντες.
Patent CY-1115992-T1 (CY)
Title: Οξαζολο υποκατεστημενα ινδαζολια ως αναστολεις ρι3-κινασης
Inventor: HAMBLIN JULIE NICOLE
IPC: A61K31/4439
Filed: 2015-02-12
Abstract: Η εφεύρεση κατευθύνεται σε ορισμένες νέες ενώσεις. Ειδικώς, η εφεύρεση κατευθύνεται σε ενώσεις του τύπου (I): και άλατα αυτών. Οι ενώσεις της εφεύρεσης είναι αναστολείς δραστικότητας κινάσης, ιδιαιτέρως δραστικότητας ΡΙ3-κινάσης.
Patent CY-1119556-T1 (CY)
Title: Περικομμενα θραυσματα της αλφα-συνουκλεϊνης σε νοσο με σωματια lewy
Inventor: CHILCOTE TAMIE J
IPC: C12Q1/68
Filed: 2017-09-20
Abstract: Η αίτηση ταυτοποιεί νέα θραύσματα της άλφα συνουκλεΐνης σε ασθενείς με νόσο με σωμάτια Lewy (LBD) και διαγονιδιακά ζωικά μοντέλα αυτής. Αυτές οι ασθένειες χαρακτηρίζονται από συσσωματώσεις άλφα συνουκλεΐνης. Τα θραύσματα έχουν ένα περικομμένο C-τερματικό άκρο σε σχέση με την πλήρους μήκους άλφα συνουκλεΐνη. Μερικά θραύσματα χαρακτηρίζονται από ένα μοριακό βάρος περίπου 12 kDa όπως προσδιορίσθηκε με SDS ηλεκτροφόρηση σε πήκτωμα σε ρυθμιστικό διάλυμα τρυκίνης και μία περικοπή τουλάχιστον δέκα συνεχόμενων αμινοξέων από το C-τερματικό άκρο της φυσικής άλφα συνουκλεΐνης. Η θέση διάσπασης κατά προτίμηση είναι μετά από κατάλοιπο (117) και πριν από κατάλοιπο (126) της φυσικής άλφα συνουκλεΐνης. Η ταυτοποίηση αυτών των νέων θραυσμάτων της άλφα συνουκλεΐνης έχει έναν αριθμό εφαρμογών σε για παράδειγμα, ανακάλυψη φαρμάκων, διαγνωστικά, θεραπευτικά και διαγονιδιακά ζώα.
Patent CY-1119858-T1 (CY)
Title: Πανελ με ενα αγκιστροειδες συστημα μανδαλωσης
Inventor: Ο ΕΦΕΥΡΈΤΗΣ
IPC: E04F15/10
Filed: 2017-12-18
Abstract: Η εφεύρεση αναφέρεται σε ένα πάνελ (1, 4, 5) με συμπληρωματικά προφίλ συγκράτησης, τα οποία παρέχονται κατά ζεύγη επί των ακμών του πάνελ και τα οποία είναι προσαρμοσμένα μεταξύ τους, έτσι ώστε πανομοιότυπα πάνελ να μπορούν να στερεώνονται το ένα επί του άλλου. Τουλάχιστον ένα από τα ζεύγη προφίλ συγκράτησης είναι εφοδιασμένο με προφίλ αγκίστρου, τα οποία σχηματίζονται από άγκιστρα υποδοχής (6) και απέναντι, συμπληρωματικά άγκιστρα ασφάλισης (7). Οι εσωτερικές πλευρές των άκρων των προφίλ αγκίστρου σχηματίζουν επιφάνειες μανδάλωσης (12, 13), οι οποίες είναι κεκλιμένες προς τις επιφάνειες των πάνελ, οι εξωτερικές πλευρές των άκρων των προφίλ αγκίστρου έχουν εμπλοκές (14, 15, 22, 21), οι οποίες αντισταθμίζουν μια μετατόπιση ύψους των μανδαλωμένων πάνελ και η άνω πλευρά του άκρου του αγκίστρου υποδοχής και η συμπληρωματική κάτω πλευρά της αύλακας ασφάλισης εκτείνονται μερικώς κεκλιμένες προς τα κάτω.
Patent CY-1122566-T1 (CY)
Title: Παραγωγο 6,7,8,9-tetpaϋδpo-3h-πυραζολo[4,3-f] ισοκινολινης χρησιμο στη θεραπευτικη αντιμετωπιση του καρκινου
Inventor: SCOTT JAMES STEWART
IPC: A61K31/4738
Filed: 2019-10-24
Abstract: Η εφεύρεση αναφέρεται σε ενώσεις του Τύπου (I) και σε φαρμακευτικώς αποδεκτά άλατα αυτής, σε διαδικασίες και ενδιάμεσες ενώσεις που χρησιμοποιούνται για την παρασκευή τους, σε φαρμακευτικές συνθέσεις που τις περιέχουν και στη χρήση τους στη θεραπευτική αντιμετώπιση των κυτταρικών πολλαπλασιαστικών διαταραχών.
Patent HR-P20110929-T1 (HR)
Title: Method for producing a translucent multilayer composite component for facades and a component manufactured thereby
Inventor: FISCHER OLIVER
IPC: E04C2/54
Filed: 2011-12-12
Abstract: The device has a translucent component made form a multi-layer composite component (10). A facing layer (1), made form a concrete material, is arranged on visible side. An insulating layer (2) is arranged at a distance behind the visible side. The insulating layer is connected with a back layer (3), made from concrete material, at its back side. The all three form of one or more light guidance bodies (4) are interspersed. The facing layer and the base layer has wood composite materials, mineral casting masses, concrete polymer, tone, lime, gypsum, loam, plastic masses and hard materials. An independent claim is also included for a method for producing translucent multi-layer composite components for facade and other construction.
Patent SI-1572747-T1 (SI)
Title: Tumor-specific recognition molecules
Inventor: GOLETZ STEFFEN
IPC: C07K16/00
Filed: 2003-12-01
Abstract: Recognition molecules (RM), especially antibodies (A) that bind specifically to the Core-1 (C1) antigen, comprising defined amino acids sequences (1-6) given in the specification and below, are new. Recognition molecules (RM), especially antibodies (A) that bind specifically to the Core-1 (C1) antigen, comprising defined amino acids sequences (1-6): (a) AsnTyrTrpLeuGly (1); (b) AspIleTyrPro(Gly) 3TyrThrAsnTyrAsnGluLysPheLysGly (2); (c) AspIleTyrPro(Gly) 2SerTyrThrAsnTyrAsnGluLysPheLysGly (3); (d) TyrAspAlaAlaGlyProTrpPheAlaTyr (4); (e) TyrAspAlaAlaGlyProGlyPheAlaTyr (5); or (f) TyrAspAsnHisTyrPheAspTyr (6). Independent claims are also included for: (1) construct (B) consisting of (A) fused, chemically coupled or non-covalently associated with additional sequences and/or structures; (2) isolated nucleic acid (NA) containing sequences that encode at least one (A) or (B); (3) expression cassette or vector (X) comprising NA and functionally linked promoter; (4) virus or host cell that contains at least one (X); (5) organism that contains at least one host cell of (4); (6) method for preparing (A); and (7) kit containing (A) and/or (B). ACTIVITY : Cytostatic. A multibody (104; sequence of about 200 amino acids reproduced) was coupled to a chelating group then loaded with yttrium99. It was injected (dose 100 MicroCi) into the tail vein of a mouse, subcutaneously implanted with ZA-75-1 (Core-1 positive) tumor cells. A second dose was given after 3 weeks and this treatment produced a significant reduction in tumor growth (no figures given). MECHANISM OF ACTION : Neutralization of Core-1 antigen; Vaccine.
Patent SI-1793859-T1 (SI)
Title: Treatment of oral and intestinal mucositis by administering human il-18
Inventor: LEE JUDITHANN
IPC: A61K38/00
Filed: 2005-08-18
Abstract: The present invention relates generally to the use of human IL-18, also known as interferon-³-inducing factor (IGIF), in the treatment of skin wounds, surgical wounds, leg ulcers, diabetic ulcers, gastrointestinal mucositis, oral mucositis, and lung injury.
Patent SI-1758066-T1 (SI)
Title: Arrangement of an vehicle unit OBU with an identification protection unit to prevent unauthorized use
Inventor: SVITEK MIROSLAV
IPC: G08G1/00
Filed: 2006-08-16
Abstract: An arrangement of the vehicle unit OBU (5) in the telematic system, especially for transport elements (16), characterised in that the separated identification protection unit (2), which is safely mechanically secured to a transport element (16) is, by means of a communication interface (6) and a control logic (3), assigned to a vehicle unit OBU (5) and that said identification protection unit (2) constitutes, together with the vehicle unit OBU (5) and the control logic (3) the secured telematic identifier (1) of the transport element (16) for its clear and provable identification as well as position identification and/or for the identification of driven-off geographical segment / sector in connection to supervising and control centres (10), which are provided with data bases (12) of these identification protection units (2) in order to have these units compared by the control logic (11) of at least one supervising and control centre (10) and this through any freely selected mobile phone network operator, whereby the identification protection unit (2) and/or the control logic (3) is fitted, for ensuring security, integrity and protection of the transport element (16), with a micro chip with security codes and special keys with specific cryptologic functions and unique recognition, classification, and identification data of the transport element (16) and/or shipment features and/or its parts.
Patent SI-2094593-T1 (SI)
Title: Workpiece carrier for conveying a workpiece to be painted
Inventor: WESCHKE JURGEN
IPC: B62D65/00
Filed: 2007-11-09
Abstract: In order to create a workpiece carrier for conveying a workpiece to be painted, in particular, a vehicle body through at least one electrophoretic dip paint bath and by means of at least one conveyor device following the electrophoretic dip paint bath, comprising at least one electrical contacting device for passing a coating current into the workpiece when the workpiece is conveyed through the electrophoretic dip paint bath and at least one contact surface, at which the workpiece carrier comes into contact with the conveyor device following the electrophoretic dip paint bath, with which dip paint is prevented from rubbing off in the conveyor device following the electrophoretic dip paint bath, it is suggested that at least one contact surface be electrically insulated from the at least one contacting device.
Patent SI-2209936-T1 (SI)
Title: Machine for cleaning, washing, drying and ironing clothes and garments
Inventor: ZAGLIO SERGIO
IPC: A47G25/00
Filed: 2008-10-07
Abstract: The present invention relates to a multifunction machine for laundries, which comprises a body or frame (11) defining a treatment chamber (12) hermetically closed and equipped with means (15) for hanging elements (14), such as bed linen, clothes and garments, to be treated; means for removing stains, a wash and rinse; means for drying; and means for ironing said elements while they are hanging and stretched out in said treatment chamber.
Patent TR-200700380-T1 (TR)
Title: Gıda maddeleri üzerine kabartma desenler basma yöntemi ve cihazı.
Inventor: TRENDAFILOV YORDAN DIMITROV
IPC: A01J27/00
Filed: 2005-07-19
Abstract: Üzerine dayanıklı yüzeysel bir kabartma desen baskısı basılan gıda maddeleri üzerine kabartma desenler basma yöntemi. Seçilen dozlandırılmış hacimde gıda maddesi, tekstil malzemesinden bir bez (1) üzerine yerleştirilir; üzerine, önceden belirlenen sıklıkta ve durumda işlemeli konveks kabartma elementleri (2) yapılır. Başlangıçtaki nemin gıda maddelerinden giderilmesinin ve bunun yüzeyinin tatminkar dayanıklılıkta sertleşmesinin ardından, üretilmiş gıdanın her bir parçasının yüzeyi üzerinde, tekstil malzemesinden bez (1) üzerine işlenmiş konveks kabartma elementlerinin (2) ayna görüntüleri olan konkav kabartma elementlerinden (3) dayanıklı bir baskı oluştuğunda, tekstil malzemesinden bez (1)çıkarılır.
Patent DE-3588043-T2 (DE)
Inventor: CARDIFF ROBERT
IPC: C07K16/00
Filed: 1985-01-03
Granted: 1996-03-21
Abstract: Methods and compositions are provided for identifying patients suffering from neoplastic diseases such as breast cancer. It has been found that neoplastic epithelial cells, including neoplastic mammary epithelial cells, release a particular N-terminal blocked, soluble cytokeratin into circulation. The presence of this cytokeratin is diagnostic of neoplastic disease.
Patent DE-3686913-T2 (DE)
Inventor: TAKAHASHI TAKAO
IPC: G11B27/032
Filed: 1986-07-08
Granted: 1993-02-18
Abstract: An apparatus for recording and/or reproducing an information signal such as a PCM (pulse code modulated) signal and the like is disclosed, in which an index signal (IDX) is inserted (recorded) into a predetermined area portion at a position extended to a recording area of the PCM signal recorded by a rotary head (HA, HB) or the index signal (IDX) recorded is erased therefrom, an area specifying signal which specifies the area of this index signal (IDX) is formed on the basis of an address data (ADRS) in the reproduced PCM signal. According to the apparatus of the invention, the index signal area is always determined at a position having a predetermined positional relation to a recording area (13, 23) of the PCM signal so that when the index signal is inserted into or erased from the index area, the PCM signal portion and other signal can be prevented from being erased.
Patent DE-3688229-T2 (DE)
Inventor: GANNON JOHN ROBERT
IPC: B29D11/00
Filed: 1986-09-25
Granted: 1993-07-22
Abstract: An optical fibre cable element (3A) for incorporation in an optical fibre cable (Fig. 4) for e.g. local area networks, comprises a plurality of optical fibres (3) held together solely by an adhesive which has been applied cold and air-dried. A suitable adhesive material is a solvent-based acrylic copolymer system. Preferably the shape of the cable element is a ribbon, but other constructions are also envisaged. The cable element is cheap to make and avoids the heat and pressure of extrusion in the construction of the cable element, thus minimising the risk of damaging the fibres by such heat and pressure. Very high fibre density is also achieved.
Patent DE-3782249-T2 (DE)
Inventor: THOMPSON MARION L
IPC: E01F8/00
Filed: 1987-07-01
Granted: 1993-03-11
Abstract: The barrier (10) dissipating kinetic energy upon impact by a moving vehicle comprises walls (16, 18, 20) defining a container (22) closed except for a fill opening to admit water (26). Various configurations of side walls (20) are disclosed. The side walls are resiliently deformable to return to their original shape after being struck, the resilience, thickness and deformability of the walls tending to form a capture region (72) above and in advance of the vehicle tire to slow the tire and prevent it from climbing and vaulting the barrier.